The covalent docking software landscape: features and applications in drug design
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Natesh Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Evotec SE, Molecular Architects, Integrated Drug Discovery, Campus Curie, 195 Rte d'Espagne, 31100 Toulouse, France. Hauptthemen laut MEDLINE: Drug Design, Molecular Docking Simulation, Software, Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Covalent small-molecule ligands have re-emerged as powerful tools in drug discovery, offering prolonged target engagement, enhanced potency, and the ability to modulate proteins once considered undruggable. However, the rational design and virtual screening (VS) of covalent ligands remain challenging. Many docking tools cannot accurately model the energetics of covalent bond formation, often requiring more rigorous quantum mechanical (QM) or semi-empirical QM calculations for reliable predictions. Despite these limitations, the computational landscape is rapidly evolving. An increasing number of open-source, commercial, and web-based platforms now support binding mode exploration, lead optimization, and structure-based VS of covalent ligands. Alongside traditional approaches, new artificial intelligence (AI) and machine learning (ML) tools are assisting in prioritizing candidate molecules. This review introduces the fundamental principles and mechanisms of covalent inhibition, then provides a comprehensive overview of computational tools including covalent docking, warhead placement algorithms, and pharmacophore modeling, supporting early-stage drug discovery and chemical biology. Case studies highlight practical applications. We also cover curated databases of covalent binders and experimental 3D protein–ligand complexes, plus tools for assessing nucleophilic residue reactivity, all essential for robust covalent modeling. Finally, we briefly address risks associated with covalent chemistry. While progress is notable, further advances are needed. Nonetheless, today’s covalent docking and AI-driven tools already make a meaningful impact by enabling rational design, generating new ideas, refining hypotheses, and expanding the boundaries of druggability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Evotec SE, Molecular Architects, Integrated Drug Discovery, Campus Curie, 195 Rte d'Espagne, 31100 Toulouse, France.
- Université Paris Cité, Inserm UMR 1141, Hopital Robert-Debré, 48 boulevard Sérurier, 75019 Paris, France.
ORCID-Profile: Natesh Singh, Bruno O Villoutreix
Zitieren
APA
Singh, N., Vayer, P., & Villoutreix, B. O. (2025). The covalent docking software landscape: features and applications in drug design. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf697
Vancouver
Singh N, Vayer P, Villoutreix BO. The covalent docking software landscape: features and applications in drug design. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf697
BibTeX
@article{Singh2025,
author = {Singh, Natesh and Vayer, Philippe and Villoutreix, Bruno O},
title = {The covalent docking software landscape: features and applications in drug design},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf697}
}
EUVIMED